A case of intestinal amoebiasis mimicking intestinal Behçet's disease.
Behçet’s disease
entamoeba histolytica
immunosuppressive therapy
intestinal Behçet’s disease
intestinal amoebiasis
Journal
Modern rheumatology case reports
ISSN: 2472-5625
Titre abrégé: Mod Rheumatol Case Rep
Pays: England
ID NLM: 101761026
Informations de publication
Date de publication:
24 06 2022
24 06 2022
Historique:
received:
17
01
2022
revised:
21
02
2022
accepted:
16
03
2022
pubmed:
8
4
2022
medline:
28
6
2022
entrez:
7
4
2022
Statut:
ppublish
Résumé
Intestinal amoebiasis is caused by Entamoeba histolytica (E. histolytica) and is characterised by cecal lesions, multiple lesions, aphthae, and multiple exudative erosions. Intestinal Behçet's disease (BD) is a chronic inflammatory disorder that is characterised by multiple ulcers. Although the aetiologies of these two bowel diseases are unrelated, they are difficult to distinguish because they present similarly with inflammation and ulcers, especially if evidence of specific pathogens is not detected. Herein, we report a case of intestinal amoebiasis in a patient with BD. The patient underwent colonoscopy four times before intestinal amoebiasis was diagnosed. As intestinal BD was initially suspected, she received high-dose glucocorticoid therapy, which exacerbated her condition. Following exacerbation, she underwent colonoscopy, and E. histolytica was revealed. Deliberate care should be taken to distinguish between intestinal amoebiasis and intestinal BD, as the appropriate treatments for these diseases are entirely different.
Identifiants
pubmed: 35388431
pii: 6564404
doi: 10.1093/mrcr/rxac028
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
270-272Informations de copyright
© Japan College of Rheumatology 2022. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.